Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - journals.sagepub.com
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
Biomarkers in inflammatory bowel disease: a practical guide.
J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - search.ebscohost.com
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
Biomarkers in inflammatory bowel disease: a practical guide.
J Clough, M Colwill, A Poullis, R Pollok… - Therap Adv …, 2024 - openaccess.sgul.ac.uk
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
[PDF][PDF] Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis, R Pollok, K Patel… - 2024 - researchgate.net
Inflammatory bowel disease (IBD) is a term used to describe two conditions, ulcerative colitis
(UC) and Crohn's disease (CD). These two diseases cause inflammation of the bowel, which …
(UC) and Crohn's disease (CD). These two diseases cause inflammation of the bowel, which …
Biomarkers in inflammatory bowel disease: a practical guide.
J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - europepmc.org
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
[HTML][HTML] Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis… - Therapeutic …, 2024 - pubmed.ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
[PDF][PDF] Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis, R Pollok, K Patel… - 2024 - openaccess.sgul.ac.uk
Inflammatory bowel disease (IBD) is a term used to describe two conditions, ulcerative colitis
(UC) and Crohn's disease (CD). These two diseases cause inflammation of the bowel, which …
(UC) and Crohn's disease (CD). These two diseases cause inflammation of the bowel, which …